Eastern Bank
DNTH icon

Eastern Bank’s Dianthus Therapeutics DNTH Stock Holding History

Eastern Bank’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$881 Hold
10
– – ﹤0.01% 1070
2026
Q2 		$975 Buy
+10
New +$873 ﹤0.01% 996

Other funds holding DNTH

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
QP Wealth Management
QP Wealth Management Eatontown, New Jersey $66.5M AUM 63.94% 1-Year Est. Return
Eagle Bay Advisors
Eagle Bay Advisors New York $137M AUM 18.51% 1-Year Est. Return
Sax Wealth Advisors
Sax Wealth Advisors Parsippany, New Jersey $3.5B AUM 13.73% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Private Trust Company
Private Trust Company Cleveland, Ohio $1.27B AUM 20.99% 1-Year Est. Return
Grove Bank & Trust
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Eastern Bank's DNTH Position: Q3 2026 in Review

Eastern Bank held its Dianthus Therapeutics (DNTH) position steady in Q3 2026 at 10 shares worth $881. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

Eastern Bank first reported a position in DNTH in Q2 2026 and has held it in 2 quarters since. The position peaked at $975 in Q2 2026. 15 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • Eastern Bank held 10 shares of Dianthus Therapeutics worth $881 as of Q3 2026.
  • Eastern Bank left its Dianthus Therapeutics share count unchanged in Q3 2026.
  • Dianthus Therapeutics made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #1070 holding.
  • Eastern Bank first reported a position in Dianthus Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Eastern Bank's Dianthus Therapeutics position peaked at $975 in Q2 2026.
  • 15 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.